5.42
price down icon7.03%   -0.41
after-market 시간 외 거래: 5.42
loading
전일 마감가:
$5.83
열려 있는:
$5.63
하루 거래량:
638.00K
Relative Volume:
0.84
시가총액:
$406.19M
수익:
$46.02M
순이익/손실:
$-70.80M
주가수익비율:
-2.978
EPS:
-1.82
순현금흐름:
$-1.61M
1주 성능:
-14.51%
1개월 성능:
-13.56%
6개월 성능:
-32.17%
1년 성능:
-73.78%
1일 변동 폭
Value
$5.34
$5.71
1주일 범위
Value
$5.34
$6.4811
52주 변동 폭
Value
$5.34
$23.64

Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile

Name
명칭
Eyepoint Pharmaceuticals Inc
Name
전화
617-926-5000
Name
주소
480 PLEASANT STREET, WATERTOWN, MA
Name
직원
0
Name
트위터
@eyepointpharma
Name
다음 수익 날짜
2025-03-05
Name
최신 SEC 제출 서류
Name
EYPT's Discussions on Twitter

EYPT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
EYPT
Eyepoint Pharmaceuticals Inc
5.42 406.19M 46.02M -70.80M -1.61M -1.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-01-07 개시 Citigroup Buy
2024-10-16 개시 Scotiabank Sector Outperform
2024-08-28 개시 Jefferies Buy
2024-01-22 개시 JP Morgan Overweight
2023-11-02 개시 Mizuho Buy
2023-04-21 개시 Robert W. Baird Outperform
2022-07-07 개시 Chardan Capital Markets Buy
2021-03-01 개시 Cowen Outperform
2021-01-28 개시 Cantor Fitzgerald Overweight
2020-04-06 다운그레이드 B. Riley FBR Buy → Neutral
2019-11-04 재개 Laidlaw Buy
2019-09-12 개시 Guggenheim Buy
모두보기

Eyepoint Pharmaceuticals Inc 주식(EYPT)의 최신 뉴스

pulisher
Mar 30, 2025

Long Term Trading Analysis for (EYPT) - news.stocktradersdaily.com

Mar 30, 2025
pulisher
Mar 28, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of “Buy” from Analysts - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

EyePoint to Present at 2025 RBC Capital Markets Ophthalmology Virtual Conference - The Manila Times

Mar 27, 2025
pulisher
Mar 27, 2025

EyePoint's CEO Takes Center Stage: Key Updates Coming at RBC Ophthalmology Conference - Stock Titan

Mar 27, 2025
pulisher
Mar 27, 2025

What is Chardan Capital’s Estimate for EYPT FY2026 Earnings? - Defense World

Mar 27, 2025
pulisher
Mar 23, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Bought by Bank of New York Mellon Corp - Defense World

Mar 23, 2025
pulisher
Mar 20, 2025

(EYPT) Investment Report - news.stocktradersdaily.com

Mar 20, 2025
pulisher
Mar 19, 2025

Mizuho maintains EyePoint stock Outperform with $30 target By Investing.com - Investing.com Australia

Mar 19, 2025
pulisher
Mar 18, 2025

Mizuho maintains EyePoint stock Outperform with $30 target - Investing.com India

Mar 18, 2025
pulisher
Mar 17, 2025

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - The Manila Times

Mar 17, 2025
pulisher
Mar 14, 2025

Li Auto, Xponential Fitness And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga India

Mar 14, 2025
pulisher
Mar 14, 2025

StockNews.com Upgrades EyePoint Pharmaceuticals (NASDAQ:EYPT) to “Sell” - Defense World

Mar 14, 2025
pulisher
Mar 12, 2025

EyePoint Pharmaceuticals at Leerink’s Conference: DuraView’s Promising Potential By Investing.com - Investing.com Canada

Mar 12, 2025
pulisher
Mar 10, 2025

Q1 EPS Estimate for EyePoint Pharmaceuticals Cut by Analyst - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Research Analysts Set Expectations for EYPT FY2025 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

EyePoint Pharmaceuticals Inc (EYPT) Reports Q3 2023 Financial Re - GuruFocus.com

Mar 09, 2025
pulisher
Mar 09, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Full-Year Results: Here's What Analysts Are Forecasting For This Year - simplywall.st

Mar 09, 2025
pulisher
Mar 08, 2025

Rhumbline Advisers Purchases 12,443 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

Chardan Capital Reiterates “Buy” Rating for EyePoint Pharmaceuticals (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 08, 2025

HC Wainwright Reaffirms Buy Rating for EyePoint Pharmaceuticals (NASDAQ:EYPT) - Defense World

Mar 08, 2025
pulisher
Mar 06, 2025

Demystifying EyePoint Pharmaceuticals: Insights From 4 Analyst Reviews - Benzinga

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals: Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright maintains EyePoint stock Buy rating, $22 target - Investing.com India

Mar 06, 2025
pulisher
Mar 06, 2025

H.C. Wainwright maintains EyePoint stock Buy rating, $22 target By Investing.com - Investing.com South Africa

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 06, 2025
pulisher
Mar 06, 2025

Despite Recent Gains, EyePoint Pharmaceuticals Insiders Are Still Down US$32k - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals: Q4 Earnings Snapshot - Midland Daily News

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highli - GuruFocus.com

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

EyePoint Pharmaceuticals Inc (EYPT) Q4 2024 Earnings Call Highlights: Navigating Challenges ... By GuruFocus - Investing.com Canada

Mar 06, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Reports 2024 Financial Results - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals (EYPT) Reports Q4 Earnings: What Key Metrics Have to Say - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

Earnings call transcript: EyePoint Pharmaceuticals Q4 2024 results show revenue beat, EPS miss - Investing.com India

Mar 05, 2025
pulisher
Mar 05, 2025

Earnings call transcript: EyePoint Pharmaceuticals Q4 2024 results show revenue beat, EPS miss By Investing.com - Investing.com South Africa

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals (EYPT) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals Q4 2024 Earnings: Revenue Beats at $11. - GuruFocus.com

Mar 05, 2025
pulisher
Mar 05, 2025

EYEPOINT PHARMACEUTICALS Earnings Results: $EYPT Reports Quarterly Earnings - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals shares jump nearly 5% on revenue beat By Investing.com - Investing.com Australia

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals shares jump nearly 5% on revenue beat - Investing.com

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments - The Manila Times

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Pharmaceuticals, Inc. Q4 Loss Increases, Misses Estimates - Nasdaq

Mar 05, 2025
pulisher
Mar 05, 2025

EyePoint Reports Mixed Earnings: Can Its $371M War Chest and Promising Eye Disease Pipeline Deliver Returns? - StockTitan

Mar 05, 2025
pulisher
Mar 04, 2025

EyePoint Announces Participation at Upcoming Investor Conferences - The Manila Times

Mar 04, 2025
pulisher
Mar 04, 2025

Earnings To Watch: EyePoint Pharmaceuticals Inc (EYPT) Reports Q4 2024 Result - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

Eyepoint Announces Participation At Upcoming Investor Conferences - MENAFN.COM

Mar 04, 2025
pulisher
Mar 04, 2025

EyePoint Pharmaceuticals Announces Participation in Upcoming Investor Conferences - Nasdaq

Mar 04, 2025
pulisher
Mar 04, 2025

How to Watch EyePoint's March Presentations at Two Major Healthcare Investment Conferences - StockTitan

Mar 04, 2025
pulisher
Mar 03, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of “Buy” from Brokerages - Defense World

Mar 03, 2025
pulisher
Feb 28, 2025

EyePoint Pharmaceuticals (EYPT) Projected to Post Earnings on Wednesday - MarketBeat

Feb 28, 2025
pulisher
Feb 27, 2025

(EYPT) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 27, 2025

Eyepoint Pharmaceuticals Inc (EYPT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):